Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738566 · ClinicalTrials.gov registry record · NA
Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03738566: Completed NA study, sponsored by Mayo Clinic.
NCT03738566 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03738566, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is being done to see which treatment is more effective in improving the difficulty of swallowing. Researchers are comparing self-dilation to endoscopic dilation.
Primary Outcome
Number of endoscopies required in a 6 month interval in subjects who achieved at least a 10-12 mm esophageal diameter during serial dilation for refractory benign esophageal stricture (RBES) and were subsequently treated with ESDT versus standard clinical care
Interventions
- DEVICE Esophageal self-dilation therapy
- PROCEDURE Endoscopic therapy with esophageal dilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-11-21 |
| Est. Completion | 2022-05-15 |
| Phase | NA |
What the finished NCT03738566 record still lists
NCT03738566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Esophageal self-dilation therapy is the first listed.
NCT03738566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03738566 about?
NCT03738566 is a clinical study titled "Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management". This study is being done to see which treatment is more effective in improving the difficulty of swallowing. Researchers are comparing self-dilation to endoscopic dilation.
What is the current status of trial NCT03738566?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-11-21. Estimated completion is 2022-05-15.
What interventions are being tested in trial NCT03738566?
The interventions under investigation include: Esophageal self-dilation therapy (DEVICE), Endoscopic therapy with esophageal dilation (PROCEDURE).
Who is sponsoring clinical trial NCT03738566?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03738566's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI